The Irish Clinical Oncology Group t/a Cancer Trials Ireland (Cancer Trials Ireland)

Lobbying Organisation The Irish Clinical Oncology Group t/a Cancer Trials Ireland

Date published 16 May, 2023

Relevant Matter Matters involving public funds

Public Policy Area Health

Period 1 Jan, 2023 to 30 Apr, 2023

Specific Details Data Protection

Intended results Discussion

Name of person primarily responsible for lobbying on this activity Eibhlin Mulroe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Letter (1)

Date: 23rd January 2023. Letter to Minister Donnelly, Minister for Health Description: Data protection-related issues faced in health research in Irish hospitals and its long-term effect on trial activity due to Irish interpretation of GDPR in differing decisions with regard to the same trial across the country

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Stephen Donnelly Minister (Department of Health)